76210655 - CELLECTIS

Information

• Trademark
• 76210655

• Source

• Serial Number

  76210655

• Registration Number

  2872075

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  February 13, 2001
  24 years ago

• Registration Date

  August 10, 2004
  21 years ago

• Transaction Date

  December 03, 2024
  11 months ago

• Status Date

  November 13, 2024
  11 months ago

• Published for Opposition Date

  February 18, 2003
  22 years ago

• Renewal Date

  August 10, 2024
  a year ago

• Location Date

  November 13, 2024
  11 months ago

• First Use Anywhere Date

  September 01, 2001
  24 years ago

• First Use In Commerce Date

  September 01, 2001
  24 years ago

• Status Code

  800

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  CHARLON, BARNEY

• Attorney Docket Number

  SANT-0343/US

  Attorney Name

  Mary Margaret L. O'Donnell

• Owners

  • Cellectis S.A.

Case File Statements

• GS0091: [ Scientific devices and instruments enabling implementation of biochemical analysis techniques and molecular biology techniques, namely automated biochemical analyser, automated protein production and protein purification devices, biochemical, biological automated assay devices, nucleic acid break analyser, analyzer for automatically measuring and researching interactions of biomolecules, device for protein-nucleic acid interaction analysis; apparatus for use in analysis and array-tests, qualitative and quantitative detection of analytes in samples, namely, DNA sequencing, receptor-ligand interaction, protein analysis, mass-spectrometry, nucleic acid hybridization and detection, thermo-cycler systems, microarray-printer, microarray-reader; scientific devices and instruments enabling the mapping of the biological activities of all molecules; information processing equipment, namely, computer software for molecular design, sequence analysis, sequence generation, design and analysis for molecules, namely polypeptides or polynucleotides used in genetic engineering, design and analysis of meganucleases and endonucleases and for design and analysis of genetic recombination systems, hardware and component parts, namely, processors, memory banks, peripheral controllers; multimedia products, namely, prerecorded magnetic tapes, CD-ROMs, containing image and sound recordings in the fields of chemistry, biology, biochemistry, molecular biology, bacteriology; software programs namely, software for providing an on-line computer database in the field of pharmaceuticals and biotechnology; software for searching, retrieving, storing, maintaining and managing data in the field of pharmaceuticals and biotechnology; software for use in the field of scientific information management; software for use in drug discovery; software for biomolecules analysis, nucleic acids and proteins sequences evaluation, chemical, medical and biological data bank searches and analysis, physiological data analysis, genetic data analysis, chemical formulae analysis, structural prediction for biological and chemical molecules; software for writing biological molecule sequence; molecular design software for analysis, simulation and design of biological, chemical, and material systems; software for molecular design in the biotechnology and pharmaceutical field; software for use in biological and chemical modeling, analysis and information management; software for integrated global management ]
• GS0051: Pharmaceutical, veterinary and health-care products, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination system, cells engineered by meganulease recombination system for use in genetic or viral diseases; microorganism cultures and preparation for medical, pharmaceutical and veterinary use, namely microoganisms engineered by meganuclease recombination system for use in genetic or viral diseases, cancers and vaccines; microorganisms producing polypeptides for in vivo and vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination system for use in genetic or viral diseases; bacteriological preparations for medical, pharmaceutical and veterinary use namely bacteriological preparations engineered by meganuclease recombination system; bacteriological preparations producing polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination system; drugs for veterinary use, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic and acid vectors, molecular scissors for use in genetic or viral diseases; biological preparation for medical, pharmaceutical and veterinary use namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleaes, nucleic and vectors, molecular scissors, ready to use genomic recombination system, cells engineered by meganuclease recombination system for use in genetic or viral diseases; chemopharmaceutical preparations; diagnostic preparations for clinical or medical laboratory use
• GS0011: Chemical, biochemical, biotechnological products intended for industry, agriculture, horticulture, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors; ready to use genomic recombination system, namely, meganuclease recombination agents for use in genetic engineering of cells and animals, namely rodent and fish , for scientific, laboratory or medical research; chemical, biochemical, biotechnological and bacteriological products intended for research laboratories and control laboratories, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination agents for use in connection with cells and animals for scientific, laboratory or medical research; chemical, biochemical, biotechnological products and bacteriological preparations for sciences, namely polypeptides for in vivo and in vitro genetic engineering; natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination agents for use in connection with cells and animals for scientific, laboratory or medical research; diagnostic preparation, namely natural and engineered meganucleases and endonucleases, molecular scissors for scientific or research use; proteins as raw materials; microorganisms used for producing therapeutical compounds or vaccines; chemical and biochemical preparations for medical, pharmaceutical and veterinary use, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination agents for scientific or research use
• GS0421: Scientific and industrial research; research in genetic, medical, pharmaceutical and veterinary fields; research in chemistry, biology, biochemistry, molecular biology, bacteriology; scientific analysis; research and development for others of techniques of biochemical analysis, biological analysis, molecular biology techniques; research and development for others of new molecules intended for industry; laboratory research in the fields of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy, molecular biology, agriculture; medical services; studies of technical projects in the field of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy, molecular biology, agriculture; testing, analysis and evaluation of engineering works for others; licensing of patents and intellectual property; computer programming for others, development for others of multimedia software programs

Case File Event Statements

• 6/15/2001 - 24 years ago

  2 - NON-FINAL ACTION MAILED Type: CNRT

• 6/12/2001 - 24 years ago

  1 - ASSIGNED TO EXAMINER Type: DOCK

• 12/16/2002 - 22 years ago

  11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/29/2003 - 22 years ago

  12 - NOTICE OF PUBLICATION Type: NPUB

• 11/19/2001 - 23 years ago

  4 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/21/2001 - 23 years ago

  3 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/20/2002 - 23 years ago

  5 - FINAL REFUSAL MAILED Type: CNFR

• 9/30/2002 - 23 years ago

  6 - PAPER RECEIVED Type: MAIL

• 9/30/2002 - 23 years ago

  7 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/21/2002 - 22 years ago

  8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/21/2002 - 22 years ago

  9 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 11/22/2002 - 22 years ago

  10 - EXAMINERS AMENDMENT MAILED Type: CNEA

• 2/18/2003 - 22 years ago

  13 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/11/2004 - 21 years ago

  19 - FAX RECEIVED Type: FAXX

• 5/26/2004 - 21 years ago

  22 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 5/13/2003 - 22 years ago

  14 - NOA MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 11/13/2003 - 21 years ago

  15 - PAPER RECEIVED Type: MAIL

• 11/13/2003 - 21 years ago

  16 - SOU EXTENSION 1 FILED Type: EXT1

• 12/9/2003 - 21 years ago

  17 - SOU EXTENSION 1 GRANTED Type: EX1G

• 5/11/2004 - 21 years ago

  18 - PAPER RECEIVED Type: MAIL

• 5/11/2004 - 21 years ago

  21 - USE AMENDMENT FILED Type: IUAF

• 5/21/2004 - 21 years ago

  20 - CASE FILE IN TICRS Type: CFIT

• 6/1/2004 - 21 years ago

  24 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR

• 8/6/2010 - 15 years ago

  26 - TEAS SECTION 8 & 15 RECEIVED Type: E815

• 2/10/2015 - 10 years ago

  32 - TEAS SECTION 8 & 9 RECEIVED Type: E89R

• 5/26/2004 - 21 years ago

  23 - ASSIGNED TO EXAMINER Type: DOCK

• 8/10/2004 - 21 years ago

  25 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 8/6/2010 - 15 years ago

  28 - REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED Type: 815F

• 8/27/2010 - 15 years ago

  27 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 8/27/2010 - 15 years ago

  29 - REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15P

• 2/10/2015 - 10 years ago

  30 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 2/10/2015 - 10 years ago

  31 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 8/10/2023 - 2 years ago

  36 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Type: REM2

• 10/18/2023 - 2 years ago

  38 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 10/18/2023 - 2 years ago

  40 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 2/12/2015 - 10 years ago

  33 - REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Type: 89AG

• 2/12/2015 - 10 years ago

  34 - REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Type: RNL1

• 2/12/2015 - 10 years ago

  35 - NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Type: NA89

• 10/18/2023 - 2 years ago

  41 - TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED Type: EWOR

• 10/18/2023 - 2 years ago

  42 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 10/18/2023 - 2 years ago

  43 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 10/18/2023 - 2 years ago

  39 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 11/10/2024 - 12 months ago

  45 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 11/13/2024 - 11 months ago

  47 - REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) Type: RNL2

• 11/13/2024 - 11 months ago

  46 - REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Type: 89AG

• 11/13/2024 - 11 months ago

  48 - NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Type: NA89

• 8/12/2024 - a year ago

  44 - TEAS SECTION 8 & 9 RECEIVED Type: E89R

• 10/18/2023 - 2 years ago

  37 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR